This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Abhi Bhat, PhD
Senior VP Chemistry and Head of Discovery at Rayze Bio


Abhi is the Sr. VP & Head of Discovery at RayzeBio and has over 20 years of broad cross functional drug discovery experience spanning bio-conjugates, small molecules, and peptides across multiple therapeutic areas. Most recently, Abhi was the Sr. VP and Head of R&D at Design Therapeutics where he led the discovery efforts in identifying the lead clinical asset for treatment of Friedrich ataxia along with a preclinical pipeline of GeneTAC™ molecules for treating nucleotide repeat disorders. Abhi was previously the CSO at Pyramid Biosciences where he oversaw the development of two distinct Trk-Kinase inhibitors currently in clinical development for oncology and dermatology indications. Prior to Pyramid, Abhi held R&D leadership roles at Ipsen, Redwood, Pfizer and CovX where he led projects from concept validation through early clinical development in oncology, metabolic diseases, pain and inflammation. Abhi received his PhD from The Ohio State University and conducted postdoctoral research at the Univ. of Arizona.

Agenda Sessions

  • Advancing the Science of Radiopharmaceutical Therapy: A Renewed Hope for New Cancer Treatments